SPARK: Safety Study of Pradaxa in Atrial Fibrillation Patients by Regulatory Requirement of Korea
Status:
Completed
Trial end date:
2017-02-17
Target enrollment:
Participant gender:
Summary
This is a prospective, non-interventional, open-label, multi-centre study. It will provide
additional safety information of Pradaxa in Korean patients with non-valvular AF in clinical
settings.